{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:41:38Z","timestamp":1784734898232,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijgc.2026.104619","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:32:45Z","timestamp":1771605165000},"page":"104619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prognostic value of p53 abnormal expression in non-myoinvasive endometrial cancer: a retrospective comparative study according to p53 status and myometrial invasion"],"prefix":"10.1016","volume":"36","author":[{"given":"Anna","family":"Giudici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4509-0287","authenticated-orcid":false,"given":"Vicenzo","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-8666","authenticated-orcid":false,"given":"Luigi A.","family":"De Vitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7802-8261","authenticated-orcid":false,"given":"Lucia","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mezzapesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-2502","authenticated-orcid":false,"given":"Emilia","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Shelden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela E.","family":"McGree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Fought","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-5410","authenticated-orcid":false,"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9519-1097","authenticated-orcid":false,"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8059-1602","authenticated-orcid":false,"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6818-2412","authenticated-orcid":false,"given":"Evelyn A.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijgc.2026.104619_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ijgc-2020-002256","article-title":"p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification","volume":"31","author":"Jamieson","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104619_bib2","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijgc.2026.104619_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2024.09.011","article-title":"Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: a systematic review and meta-analysis","volume":"191","author":"Anastasio","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2026.104619_bib4","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104619_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104619_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104619_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104619_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.6004\/jnccn.2025.0038","article-title":"NCCN Guidelines\u00ae insights: uterine neoplasms, version 3.2025","volume":"23","author":"Abu-Rustum","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104619_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.ijgc.2026.104619_bib10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104619_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104619_bib12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5858\/arpa.2015-0220-OA","article-title":"Interobserver variability in the diagnosis of uterine high-grade endometrioid carcinoma","volume":"140","author":"Thomas","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"23","key":"10.1016\/j.ijgc.2026.104619_bib13","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas","volume":"29","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res."},{"issue":"12","key":"10.1016\/j.ijgc.2026.104619_bib14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41379-022-01165-w","article-title":"Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification","volume":"35","author":"Thompson","year":"2022","journal-title":"Mod Pathol."},{"issue":"9","key":"10.1016\/j.ijgc.2026.104619_bib15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin Cancer Res."},{"issue":"8","key":"10.1016\/j.ijgc.2026.104619_bib16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/ijgc-2020-001379","article-title":"Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium","volume":"30","author":"Nasioudis","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104619_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2022.09.025","article-title":"Adjuvant therapy in women with early stage uterine serous carcinoma: a multi-institutional study","volume":"167","author":"Kurnit","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104619_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ijgc-2023-005149","article-title":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104619_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/ijgc-2023-005173","article-title":"Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study","volume":"34","author":"De Vitis","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104619_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(24)00142-6","article-title":"Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials","volume":"25","author":"Wakkerman","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104619_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/aogs.14015","article-title":"Age is an independent predictor of outcome in endometrial cancer patients: an Israeli Gynecology Oncology Group cohort study","volume":"100","author":"Hag-Yahia","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104619_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2012.04.011","article-title":"The prognostic significance of age in surgically staged patients with type II endometrial carcinoma","volume":"126","author":"Vance","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104619_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2025.04.576","article-title":"Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer","volume":"197","author":"Le\u00f3n-Castillo","year":"2025","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104619_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ygyno.2025.05.004","article-title":"Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma","volume":"197","author":"Wagar","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104619_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:05:43Z","timestamp":1777885543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1048891X26001507"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104619","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of p53 abnormal expression in non-myoinvasive endometrial cancer: a retrospective comparative study according to p53 status and myometrial invasion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104619"}}